[1]

Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, et al. 2021. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet 397:2337−2360

doi: 10.1016/S0140-6736(21)01169-7
[2]

Meza R, Cao P, Jeon J, Warner KE, Levy DT. 2023. Trends in US adult smoking prevalence, 2011 to 2022. JAMA Health Forum 4:e234213

doi: 10.1001/jamahealthforum.2023.4213
[3]

Carpenter MJ, Jardin BF, Burris JL, Mathew AR, Schnoll RA, et al. 2013. Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. Drugs 73:407−426

doi: 10.1007/s40265-013-0038-y
[4]

Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE. 2001. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs 15:453−467

doi: 10.2165/00023210-200115060-00004
[5]

Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, et al. 2009. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry 66:1253−1262

doi: 10.1001/archgenpsychiatry.2009.142
[6]

Schnoll RA, Goelz PM, Veluz-Wilkins A, Blazekovic S, Powers L, et al. 2015. Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Internal Medicine 175:504−511

doi: 10.1001/jamainternmed.2014.8313
[7]

Farrelly MC, Chaloupka FJ, Berg CJ, Emery SL, Henriksen L, et al. 2017. Taking stock of tobacco control program and policy science and impact in the United States. Journal of Addictive Behaviors and Therapy 1:8

[8]

Wakefield TD, Glantz SA. 2022. Securing smokefree laws covering casinos and bars in louisiana via messaging, continuous campaigning and health coalitions. International Journal of Environmental Research and Public Health 19:3936

doi: 10.3390/ijerph19073936
[9]

Bafunno D, Catino A, Lamorgese V, Del Bene G, Longo V, et al. 2020. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. Journal of Thoracic Disease 12:3844−3856

doi: 10.21037/jtd.2020.02.23
[10]

Zvolska K, Pankova A, Nohavova I, Huque R, Elsey H, et al. 2020. A narrative review of facilitators and barriers to smoking cessation and tobacco-dependence treatment in patients with tuberculosis in low- and middle-income countries. Tobacco Induced Diseases 18:67

doi: 10.18332/tid/125195
[11]

Trigg J, Skelton E, Lum A, Guillaumier A, McCarter K, et al. 2023. Smoking cessation interventions and abstinence outcomes for people living in rural, regional, and remote areas of three high-income countries: a systematic review. Nicotine and Tobacco Research 25:1709−1718

doi: 10.1093/ntr/ntad098
[12]

Cullen KA, Gentzke AS, Sawdey MD, Chang JT, Anic GM, et al. 2019. E-cigarette use among youth in the United States, 2019. JAMA 322:2095−2103

doi: 10.1001/jama.2019.18387
[13]

Dai H, Leventhal AM. 2019. Prevalence of e-cigarette use among adults in the United States, 2014−2018. JAMA 322:1824−1827

doi: 10.1001/jama.2019.15331
[14]

Villarroel MA, Cha AE, Vahratian A. 2020. Electronic cigarette use among U.S. adults, 2018. NCHS Data Brief 2020:1−8

[15]

Huang J, Duan Z, Kwok J, Binns S, Vera LE, et al. 2019. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tobacco Control 28:146−151

doi: 10.1136/tobaccocontrol-2018-054382
[16]

Majmundar A, Okitondo C, Xue A, Asare S, Bandi P, et al. 2022. Nicotine pouch sales trends in the US by volume and nicotine concentration levels from 2019 to 2022. JAMA Network Open 5:e2242235

doi: 10.1001/jamanetworkopen.2022.42235
[17]

Trigger S, Xu X, Malarcher A, Salazar E, Shin H, et al. 2023. Trends in over-the-counter nicotine replacement therapy sales, U.S., 2017‒2020. American Journal of Preventive Medicine 64:650−657

doi: 10.1016/j.amepre.2022.12.008
[18]

Wang TW, Neff LJ, Park-Lee E, Ren C, Cullen KA, et al. 2020. E-cigarette use among middle and high school students − United States, 2020. Morbidity and Mortality Weekly Report (MMWR) 69:1310−1312

doi: 10.15585/mmwr.mm6937e1
[19]

Huang J, Wang Y, Duan Z, Kim Y, Emery SL, et al. 2021. Do e-cigarette sales reduce the demand for nicotine replacement therapy (NRT) products in the US? Evidence from the retail sales data. Preventive Medicine 145:106376

doi: 10.1016/j.ypmed.2020.106376
[20]

Blount BC, Karwowski MP, Morel-Espinosa M, Rees J, Sosnoff C, et al. 2019. Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of e-cigarette, or vaping, product use-associated lung injury − 10 states, August-October 2019. Morbidity and Mortality Weekly Report (MMWR) 68:1040−1041

doi: 10.15585/mmwr.mm6845e2
[21]

Wackowski OA, Gratale SK, Jeong M, Delnevo CD, Steinberg MB, et al. 2023. Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest. Tobacco Control 32:e255−e259

doi: 10.1136/tobaccocontrol-2021-057190
[22]

Caponnetto P. 2020. Well-being and harm reduction, the consolidated reality of electronic cigarettes ten years later from this emerging phenomenon: a narrative review. Health Psychology Research 8:1

doi: 10.4081/hpr.2020.9463
[23]

Buettner-Schmidt K, Swanson K, Maack B, Barnacle M, Miller D, et al. 2021. E-cigarettes for tobacco cessation: not the solution. The Nurse Practitioner 46:7−11

doi: 10.1097/01.NPR.0000798228.69915.64
[24]

Kumbalatara C, Manietta L, Cortez D, Jayawardene W. 2025. Seasonal trends and sales patterns of nicotine replacement therapy (NRT) products in the US before and after the emergence of e-cigarettes, 2006−2020. American Public Health Association (APHA) 2025 Annual Meeting and Expo, 2−5 November 2025, Washington, USA. https://apha.confex.com/apha/2025/meetingapi.cgi/Paper/574635?filename=2025_Abstract574635.html&template=Word

[25]

U. S. Food and Drug Administration. 2022. Want to quit smoking? FDA-approved and FDA-cleared cessation products can help. www.fda.gov/consumers/consumer-updates/want-quit-smoking-fda-approved-and-fda-cleared-cessation-products-can-help

[26]

Statistics USBoL. 2024. Consumer Price Index Data. www.bls.gov/cpi/data.htm

[27]

Cleveland RB, Cleveland, WS, McRae JE, Terpenning IJ. 1990. STL: a seasonal-trend decomposition procedure based on loess. Journal of Official Statistics 6:3−33

[28]

Veldhuizen S, Zawertailo L, Ivanova A, Hussain S, Selby P. 2021. Seasonal variation in demand for smoking cessation treatment and clinical outcomes. Nicotine & Tobacco Research 23:976−982

doi: 10.1093/ntr/ntaa214
[29]

Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, et al. 2019. A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine 380:629−637

doi: 10.1056/NEJMoa1808779
[30]

Chan GCK, Stjepanović D, Lim C, Sun T, Shanmuga Anandan A, et al. 2021. A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation. Addictive Behaviors 119:106912

doi: 10.1016/j.addbeh.2021.106912
[31]

Hartmann-Boyce J, McRobbie H, Lindson N, Bullen C, Begh R, et al. 2020. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2020:CD010216

doi: 10.1002/14651858.cd010216.pub
[32]

Hajek P, Przulj D, Pesola F, Griffiths C, Walton R, et al. 2022. Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial. Nature Medicine 28:958−964

doi: 10.1038/s41591-022-01808-0
[33]

Evoy KE, Yett ES, Ramey O, Lodise N. 2025. Evidence regarding e-cigarettes as a harm reduction strategy and treatment for e-cigarette cessation: an overview and guide for clinicians. JACCP: Journal of the American College of Clinical Pharmacy 8:895−905

doi: 10.1002/jac5.70092
[34]

Jayawardene W, Kumbalatara C, Dufner M, Tran P, Redner R. 2025. Vaping cessation attempts and intentions among undergraduate students: insights into interventions. Journal of College Student Mental Health 39:349−364

doi: 10.1080/28367138.2024.2365651